Salisbury Foundation Trust


Internal Reference Number: FOI_7117

Date Request Received: 11/04/2023 00:00:00

Date Request Replied To: 26/04/2023 00:00:00

This response was sent via: By Email

Request Summary: Asthma

Request Category: Companies

Question Number 1:
How many patients have been treated (for any condition) in the last 4 months with:

• Benralizumab

• Dupilumab

• Omalizumab

• Reslizumab

• Mepolizumab

• Tezepelumab
Answer To Question 1:
Dupilumab 18 patients
Omalizumab 22 patients

None of the other drugs are used at Salisbury Foundation Trust
Question Number 2:
Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age groups:

• Age 6 - 11

• Age 12 - 17

• Age 18 and above
Answer To Question 2:
All patients are aged 18 and over, no patients in lower age group.
Question Number 3:
How many patients have been treated in the last 4 months by the Respiratory Medicines Department ONLY with:

• Dupilumab

• Omalizumab
Answer To Question 3:
• Dupilumab not used
• Omalizumab 40
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe





Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E:
© 2024 Salisbury NHS Foundation Trust
Trust Values